Literature DB >> 21880983

Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence.

Jens C Krause1, Tshidi Tsibane, Terrence M Tumpey, Chelsey J Huffman, Bryan S Briney, Scott A Smith, Christopher F Basler, James E Crowe.   

Abstract

We generated from a single blood sample five independent human mAbs that recognized the Sa antigenic site on the head of influenza hemagglutinin and exhibited inhibitory activity against a broad panel of H1N1 strains. All five Abs used the V(H)3-7 and J(H)6 gene segments, but at least four independent clones were identified by junctional analysis. High-throughput sequence analysis of circulating B cells revealed that each of the independent clones were members of complex phylogenetic lineages that had diversified widely using a pattern of progressive diversification through somatic mutation. Unexpectedly, B cells encoding multiple diverging lineages of these clones, including many containing very few mutations in the Ab genes, persisted in the circulation. Conversely, we noted frequent instances of amino acid sequence convergence in the Ag combining sites exhibited by members of independent clones, suggesting a strong selection for optimal binding sites. We suggest that maintenance in circulation of a wide diversity of somatic variants of dominant clones may facilitate recognition of drift variant virus epitopes that occur in rapidly mutating virus Ags, such as influenza hemagglutinin. In fact, these Ab clones recognize an epitope that acquired three glycosylation sites mediating escape from previously isolated human Abs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880983      PMCID: PMC3178754          DOI: 10.4049/jimmunol.1101823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

Review 1.  The role of somatic hypermutation in the generation of antibody diversity.

Authors:  D L French; R Laskov; M D Scharff
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

2.  Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule.

Authors:  J W Yewdell; R G Webster; W U Gerhard
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

3.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

4.  Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus.

Authors:  James Stevens; Adam L Corper; Christopher F Basler; Jeffery K Taubenberger; Peter Palese; Ian A Wilson
Journal:  Science       Date:  2004-02-05       Impact factor: 47.728

5.  Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.

Authors:  Michael Zemlin; Martin Klinger; Jason Link; Cosima Zemlin; Karl Bauer; Jeffrey A Engler; Harry W Schroeder; Perry M Kirkham
Journal:  J Mol Biol       Date:  2003-12-05       Impact factor: 5.469

6.  IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties.

Authors:  Christelle Pommié; Séverine Levadoux; Robert Sabatier; Gérard Lefranc; Marie-Paule Lefranc
Journal:  J Mol Recognit       Date:  2004 Jan-Feb       Impact factor: 2.137

7.  An insertion mutation that distorts antibody binding site architecture enhances function of a human antibody.

Authors:  Jens C Krause; Damian C Ekiert; Terrence M Tumpey; Patricia B Smith; Ian A Wilson; James E Crowe
Journal:  MBio       Date:  2011-02-08       Impact factor: 7.867

8.  Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections.

Authors:  R Küppers; M Zhao; M L Hansmann; K Rajewsky
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

9.  Molecular analysis of original antigenic sin. I. Clonal selection, somatic mutation, and isotype switching during a memory B cell response.

Authors:  S Fish; E Zenowich; M Fleming; T Manser
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors.

Authors:  L A Herzenberg; S J Black; T Tokuhisa; L A Herzenberg
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  51 in total

1.  Genetic measurement of memory B-cell recall using antibody repertoire sequencing.

Authors:  Christopher Vollmers; Rene V Sit; Joshua A Weinstein; Cornelia L Dekker; Stephen R Quake
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

2.  De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts.

Authors:  Jiang Zhu; Xueling Wu; Baoshan Zhang; Krisha McKee; Sijy O'Dell; Cinque Soto; Tongqing Zhou; Joseph P Casazza; James C Mullikin; Peter D Kwong; John R Mascola; Lawrence Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-08       Impact factor: 11.205

3.  Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.

Authors:  Donald M Carter; Christopher A Darby; Bradford C Lefoley; Corey J Crevar; Timothy Alefantis; Raymond Oomen; Stephen F Anderson; Tod Strugnell; Guadalupe Cortés-Garcia; Thorsten U Vogel; Mark Parrington; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

4.  Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.

Authors:  Scott A Smith; Laurie A Silva; Julie M Fox; Andrew I Flyak; Nurgun Kose; Gopal Sapparapu; Solomiia Khomandiak; Solomiia Khomadiak; Alison W Ashbrook; Kristen M Kahle; Rachel H Fong; Sherri Swayne; Benjamin J Doranz; Charles E McGee; Mark T Heise; Pankaj Pal; James D Brien; S Kyle Austin; Michael S Diamond; Terence S Dermody; James E Crowe
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

5.  Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.

Authors:  Susanne L Linderman; Benjamin S Chambers; Seth J Zost; Kaela Parkhouse; Yang Li; Christin Herrmann; Ali H Ellebedy; Donald M Carter; Sarah F Andrews; Nai-Ying Zheng; Min Huang; Yunping Huang; Donna Strauss; Beth H Shaz; Richard L Hodinka; Gustavo Reyes-Terán; Ted M Ross; Patrick C Wilson; Rafi Ahmed; Jesse D Bloom; Scott E Hensley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

Review 6.  The evolution within us.

Authors:  Sarah Cobey; Patrick Wilson; Frederick A Matsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

Review 7.  Rationalizing Random Walks: Replicating Protective Antibody Trajectories.

Authors:  Jennifer L Remmel; Margaret E Ackerman
Journal:  Trends Immunol       Date:  2021-01-26       Impact factor: 16.687

Review 8.  Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.

Authors:  James E Crowe
Journal:  Cell Host Microbe       Date:  2017-08-09       Impact factor: 21.023

9.  High frequency of shared clonotypes in human B cell receptor repertoires.

Authors:  Cinque Soto; Robin G Bombardi; Andre Branchizio; Nurgun Kose; Pranathi Matta; Alexander M Sevy; Robert S Sinkovits; Pavlo Gilchuk; Jessica A Finn; James E Crowe
Journal:  Nature       Date:  2019-02-13       Impact factor: 49.962

10.  H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.

Authors:  Natalie J Thornburg; Heng Zhang; Sandhya Bangaru; Gopal Sapparapu; Nurgun Kose; Rebecca M Lampley; Robin G Bombardi; Yingchun Yu; Stephen Graham; Andre Branchizio; Sandra M Yoder; Michael T Rock; C Buddy Creech; Kathryn M Edwards; David Lee; Sheng Li; Ian A Wilson; Adolfo García-Sastre; Randy A Albrecht; James E Crowe
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.